These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23777828)

  • 1. Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
    Buemi MR; De Luca L; Chimirri A; Ferro S; Gitto R; Alvarez-Builla J; Alajarin R
    Bioorg Med Chem; 2013 Aug; 21(15):4575-80. PubMed ID: 23777828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Costa L; Ciranna L; Prezzavento O; Arena E; Ronsisvalle S; Bruno G; Chimirri A
    J Med Chem; 2011 Dec; 54(24):8702-6. PubMed ID: 22050212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Chisari M; Ciranna L; Chimirri A
    J Med Chem; 2012 Dec; 55(23):10532-9. PubMed ID: 23140383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles.
    Buemi MR; De Luca L; Ferro S; Gitto R
    Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Russo E; De Sarro G; Chisari M; Ciranna L; Alvarez-Builla J; Alajarin R; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(3):1040-8. PubMed ID: 24411196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
    Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
    J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
    ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
    Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From NMDA receptor antagonists to discovery of selective σ₂ receptor ligands.
    Gitto R; De Luca L; Ferro S; Scala A; Ronsisvalle S; Parenti C; Prezzavento O; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Jan; 22(1):393-7. PubMed ID: 24290063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
    Pessoa-Mahana H; González-Lira C; Fierro A; Zapata-Torres G; Pessoa-Mahana CD; Ortiz-Severin J; Iturriaga-Vásquez P; Reyes-Parada M; Silva-Matus P; Saitz-Barría C; Araya-Maturana R
    Bioorg Med Chem; 2013 Dec; 21(24):7604-11. PubMed ID: 24262884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affinity.
    Jansen M; Dannhardt G
    Eur J Med Chem; 2003 Oct; 38(10):855-65. PubMed ID: 14575932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.
    Bautista-Aguilera OM; Samadi A; Chioua M; Nikolic K; Filipic S; Agbaba D; Soriano E; de Andrés L; Rodríguez-Franco MI; Alcaro S; Ramsay RR; Ortuso F; Yañez M; Marco-Contelles J
    J Med Chem; 2014 Dec; 57(24):10455-63. PubMed ID: 25418133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antioxidant properties of novel N-substituted indole-2-carboxamide and indole-3-acetamide derivatives.
    Olgen S; Coban T
    Arch Pharm (Weinheim); 2002 Jul; 335(7):331-8. PubMed ID: 12207283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
    Zampieri D; Fortuna S; Calabretti A; Romano M; Menegazzi R; Schepmann D; Wünsch B; Collina S; Zanon D; Mamolo MG
    Eur J Med Chem; 2019 Oct; 180():268-282. PubMed ID: 31319263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of novel indole lipoic acid derivatives and their antioxidant effects on lipid peroxidation.
    Gurkan AS; Karabay A; Buyukbingol Z; Adejare A; Buyukbingol E
    Arch Pharm (Weinheim); 2005 Mar; 338(2-3):67-73. PubMed ID: 15765493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.